Redefining the cell and gene therapy industry.

Mayo Clinic Hibiscus Bioventures Logo Lockup Black

Mayflower BioVentures™
A Mayo Clinic and
Hibiscus BioVentures Collaboration

Mayflower BioVentures™ is a collaboration between the Mayo Clinic and Hibiscus BioVentures to establish cell and gene therapy companies focused on addressing significant unmet medical needs for patients.

Science, Biotech, Bioventures DNA Image
Science, Biotech, Bioventures in the lab image

Harnessing Mayo Clinic’s World-Class Translational Cell and Gene Therapy Innovations

Mayflower BioVentures™ seeks to enable emerging startups to produce novel therapeutics to transform health and medicine.

Access

To next generation cell and gene therapy technologies, with a commitment to identify and develop new technologies.

Combined Network

Of clinical and business leadership and strategic collaborators.

Investigating

Novel therapeutics focused on addressing unmet patient needs and value-based pricing.

About Mayo Clinic

Mayo Clinic Logo
Mayo Clinic is a nonprofit organization committed to clinical practice, education and research, providing expert, whole person care to everyone who needs healing.
Mayo Clinic's mission is to inspire hope and contribute to health and well-being by providing the best care to every patient.
Mayo Clinic’s primary value is "The needs of the patient come first."

About Hibiscus BioVentures

Hibiscus Bio Ventures Logo Stacked
Building patient-focused companies around transformative technologies.
Hibiscus BioVentures provides the Technology, Capital and People necessary to build transformative biotechnology companies
Committed to significantly moving patient care forward by supporting development of commercially viable therapeutics and diagnostics. Providing all the resources necessary in-house to identify major unmet medical needs and drive impactful solutions for patients.

Mayflower BioVentures™ program is led by a distinguished team of medical, marketing, business and technology professionals with extensive backgrounds in research and emerging product development.

LATEST NEWS

LATEST NEWS

LATEST NEWS

LATEST NEWS

LATEST NEWS

LATEST NEWS

LATEST NEWS

LATEST NEWS

Contact Us